Preview

Medicine and ecology

Advanced search

MULTISYSTEM INFLAMMATORY SYNDROME TEMPORARILY ASSOCIATED WITH COVID-19 IN CHILDREN: OWN CLINICAL OBSERVATION

Abstract

In most cases, COVID-19 is easier in children than in adults. However, starting in March 2020, from a number of European countries and the United States, there have been reports of children with a new disease, showing signs of Kawasaki and toxic shock syndrome, which have received one of the names - pediatric inflammatory multisystem syndrome temporally associated with COVID-19. The largest number of clinical and laboratory-instrumental manifestations and outcomes of pediatric inflammatory multisystem syndrome associated with COVID-19 were carried out in Italy, France, Switzerland, England, and the United States. A retrospective analysis of the medical histories of 5 children diagnosed with inflammatory multisystem syndrome associated with COVID-19, hospitalized at the Infection Center of the Regional Clinical Hospital, was carried out.

About the Authors

R. Kh. Begaidarova
Karaganda Medical University
Kazakhstan


A. G. Giniyat
Ministry of Heath of the Republic of Kazakhstan
Kazakhstan


A. V. Slugin
Regional Clinical Hospital
Kazakhstan


A. S. Saramanova
Regional Clinical Hospital
Kazakhstan


G. E. Nasakayeva
Karaganda Medical University
Kazakhstan


A. Ye. Dyusembayeva
Karaganda Medical University
Kazakhstan


Kh. D. Talipbekova
Karaganda Medical University
Kazakhstan


O. A. Zolotaryova
Karaganda Medical University
Kazakhstan


G. M. Omarova
Karaganda Medical University
Kazakhstan


A. K. Tokhmetova
Karaganda Medical University
Kazakhstan


References

1. Детский мультисистемный воспалительный синдром, ассоциированный с новой коронавирусной инфекцией (COVID-19): актуальная информация и клиническое наблюдение /М. Г. Кантемирова, Ю. Ю. Новикова, Д. Ю. Овсянников и др. //Педиатрическая фармакология. - 2020. - №17 (3). - С. 219-229.

2. Клинический протокол диагностики и лечения «Коронавирусная инфекция COVID-19 у детей» №117. 16.10.2020. РЦРЗ, МЗ РК.

3. Коронавирусная инфекция у детей /Н. Н. Зверева, М. А. Сайфуллин, А. Ю. Ртищев и др. //Педиатрия. - 2020. - №99 (2). - С. 270-278.

4. Намазова-Баранова Л. С. Короновирусная инфекция (COVID-19) у детей (состояние на апрель 2020) //Педиатрическая фармакология. - 2020. - Т. 17. - №2. - С. 93-94.

5. Патогенез COVID-19 /А. Е. Абатуров, Е. А. Агафонова, Е. Л. Кривуша, А. А. Никулина //Zdorov'e Rebenka. - 2020. - №15 (2). - P. 133-144.

6. Патологическая анатомия COVID-19 / О. В. Зайратьянц, М. В. Самсонова, Л. М. Михалева и др. //Атлас /Под общ. ред. О. В. Зайратьянца. - М.: ДЗМ, 2020. - 116 с.

7. Association between a novel human coronavirus and Kawasaki disease /F. Esper, E. D. Shapiro, C. Weibel et al. //J. Infect Dis. - 2005. -V. 191. - P. 499-502.

8. CDC COVID-19 Response Team. Coronavirus disease 2019 in children. United States, February 12 April 2, 2020 //MMWR Morb. Mortal Wkly Rep. - 2020. - Apr. 6.

9. Centers for Disease Control and Prevention. Emergency preparedness and response: health alert network. https://emergency.cdc.gov/han/2020/han004032.asp (дата обращения: 01.06.2020)

10. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. / E. Whitaker, A. Bamford, J. Kenny et al. //JAMA. Publishtd online June 8 2020 doi 10.1001/ jama.2020.10369

11. COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; a Western New York approach /T. R. Hennon, M. D. Penque, R. A. Aziz et al. //Prog. Pediatr. Cardiol. - 2020. 23:101232. Epub ahead of print. doi: 10.1016/j.ppedcard.2020.101232

12. Hyperinflomatory shock in children during COVID-19 pandemic /S. Riphagen, X. Gomes, S Gonzales Martinez et al. //Lancet. -2020. - V. 23. - P. 395(10237). - P. 1607-1608.

13. https://www.un.org/ru/global-issues/health

14. https://libmaneducation.com/kawasaki-covid-19-related- illness-in-children/(дата обращения: 11.06.2020)

15. Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in NewYork City /E. W. Cheung, P. Zachariah, M. Gorelik, A. Boneparth // JAMA. Published online June 8, 2020

16. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease /K. Shirato, Y. Imada, M. Kawase et al. //J. Med. Virol. - 2014. - V. 86. - P. 21462153.

17. Royal College of Paediatrics and Child Health. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19. https: //www.rcpch.ac.uk/ resources/guidance-paediatric-multisysteminflammatory -syndrome- temporally-associatedcovid-19 (дата обращения: 01.06.2020)

18. SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children /F. Licciardi, G. Pruccoli, M. Denina et al. //Pediatrics. - V. 146. - http: // pediatrics. aappublications. org /content/146/2/ e20201711

19. Shen K. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue /K. Shen, Y. Yang //World J. Pedi-atr. - 2020. - V. 45. - P. 1-3.

20. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children /S. Rajasekaran, K. Kruse, K. Kovey, A. T. Davis // Pediatr. Crit. Care. Med. - 2014. -V. 15(5). -P.401-408.

21. World Health Organizaition. Multisystem unflammatory syndrome in children and adolescents with COVID-19. https://www.who.int/publications-detail/multisystem-inflammatorysyn-drome-in-children- and-adolescents-with-covid-19 (дата обращения: 01.06.2020).


Review

For citations:


Begaidarova R.Kh., Giniyat A.G., Slugin A.V., Saramanova A.S., Nasakayeva G.E., Dyusembayeva A.Ye., Talipbekova Kh.D., Zolotaryova O.A., Omarova G.M., Tokhmetova A.K. MULTISYSTEM INFLAMMATORY SYNDROME TEMPORARILY ASSOCIATED WITH COVID-19 IN CHILDREN: OWN CLINICAL OBSERVATION. Medicine and ecology. 2021;(1):93-101.

Views: 199


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2305-6045 (Print)
ISSN 2305-6053 (Online)